ID   CLC2D_HUMAN             Reviewed;         191 AA.
AC   Q9UHP7; D6CI39; D6CI40; D6CI41; Q6YID5; Q8WUP7; Q9HD37; Q9HD38;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=C-type lectin domain family 2 member D;
DE   AltName: Full=Lectin-like NK cell receptor;
DE   AltName: Full=Lectin-like transcript 1;
DE            Short=LLT-1;
DE   AltName: Full=Osteoclast inhibitory lectin;
GN   Name=CLEC2D; Synonyms=CLAX, LLT1, OCIL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Natural killer cell;
RX   PubMed=10541800; DOI=10.1007/s002510050679;
RA   Boles K.S., Barten R., Kumaresan P.R., Trowsdale J., Mathew P.A.;
RT   "Cloning of a new lectin-like receptor expressed on human NK cells.";
RL   Immunogenetics 50:1-7(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INDUCTION.
RC   TISSUE=Fetal liver, and Fetus;
RX   PubMed=14753741; DOI=10.1359/jbmr.0301215;
RA   Hu Y.S., Zhou H., Myers D., Quinn J.M.W., Atkins G.J., Ly C., Gange C.,
RA   Kartsogiannis V., Elliott J., Kostakis P., Zannettino A.C.W., Cromer B.,
RA   McKinstry W.J., Findlay D.M., Gillespie M.T., Ng K.W.;
RT   "Isolation of a human homolog of osteoclast inhibitory lectin that inhibits
RT   the formation and function of osteoclasts.";
RL   J. Bone Miner. Res. 19:89-99(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 5 AND 6), ALTERNATIVE SPLICING
RP   (ISOFORMS 1 AND 2), FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, GLYCOSYLATION, AND VARIANTS LYS-19 AND VAL-23.
RC   TISSUE=Lymphocyte;
RX   PubMed=20843815; DOI=10.1074/jbc.m110.179622;
RA   Germain C., Bihl F., Zahn S., Poupon G., Dumaurier M.J., Rampanarivo H.H.,
RA   Padkjaer S.B., Spee P., Braud V.M.;
RT   "Characterization of alternatively spliced transcript variants of CLEC2D
RT   gene.";
RL   J. Biol. Chem. 285:36207-36215(2010).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   22-191 (ISOFORM 2), AND NUCLEOTIDE SEQUENCE [MRNA] OF 27-191 (ISOFORM 4).
RA   Yang G., Chen X., Davis P.M., Bowen M.A., Aruffo A.A., Kiener P.A.;
RT   "Molecular cloning of a novel CD69 homologue and its variants.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT VAL-23.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION.
RX   PubMed=15123656; DOI=10.1074/jbc.m312518200;
RA   Gange C.T., Quinn J.M.W., Zhou H., Kartsogiannis V., Gillespie M.T.,
RA   Ng K.W.;
RT   "Characterization of sugar binding by osteoclast inhibitory lectin.";
RL   J. Biol. Chem. 279:29043-29049(2004).
RN   [9]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND GLYCOSYLATION.
RX   PubMed=15104121; DOI=10.1016/j.molimm.2003.11.024;
RA   Mathew P.A., Chuang S.S., Vaidya S.V., Kumaresan P.R., Boles K.S.,
RA   Pham H.T.;
RT   "The LLT1 receptor induces IFN-gamma production by human natural killer
RT   cells.";
RL   Mol. Immunol. 40:1157-1163(2004).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16339513; DOI=10.4049/jimmunol.175.12.7796;
RA   Rosen D.B., Bettadapura J., Alsharifi M., Mathew P.A., Warren H.S.,
RA   Lanier L.L.;
RT   "Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A
RT   receptor.";
RL   J. Immunol. 175:7796-7799(2005).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 72-191, SUBUNIT, GLYCOSYLATION AT
RP   ASN-95 AND ASN-147, AND DISULFIDE BONDS.
RX   PubMed=25760607; DOI=10.1107/s1399004714027928;
RA   Skalova T., Blaha J., Harlos K., Duskova J., Koval' T., Stransky J.,
RA   Hasek J., Vanek O., Dohnalek J.;
RT   "Four crystal structures of human LLT1, a ligand of human NKR-P1, in varied
RT   glycosylation and oligomerization states.";
RL   Acta Crystallogr. D 71:578-591(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.46 ANGSTROMS) OF 71-191, SUBUNIT, AND DISULFIDE
RP   BONDS.
RX   PubMed=25826155; DOI=10.1002/eji.201545509;
RA   Kita S., Matsubara H., Kasai Y., Tamaoki T., Okabe Y., Fukuhara H.,
RA   Kamishikiryo J., Krayukhina E., Uchiyama S., Ose T., Kuroki K., Maenaka K.;
RT   "Crystal structure of extracellular domain of human lectin-like transcript
RT   1 (LLT1), the ligand for natural killer receptor-P1A.";
RL   Eur. J. Immunol. 45:1605-1613(2015).
CC   -!- FUNCTION: Receptor for KLRB1 that protects target cells against natural
CC       killer cell-mediated lysis (PubMed:20843815, PubMed:16339513). Inhibits
CC       osteoclast formation (PubMed:14753741, PubMed:15123656). Inhibits bone
CC       resorption (PubMed:14753741). Modulates the release of interferon-gamma
CC       (PubMed:15104121). Binds high molecular weight sulfated
CC       glycosaminoglycans (PubMed:15123656). {ECO:0000269|PubMed:14753741,
CC       ECO:0000269|PubMed:15104121, ECO:0000269|PubMed:15123656,
CC       ECO:0000269|PubMed:16339513, ECO:0000269|PubMed:20843815}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000269|PubMed:15104121,
CC       ECO:0000269|PubMed:20843815, ECO:0000269|PubMed:25760607,
CC       ECO:0000269|PubMed:25826155}.
CC   -!- INTERACTION:
CC       Q9UHP7-1; Q12918: KLRB1; NbExp=2; IntAct=EBI-13640978, EBI-2805465;
CC       Q9UHP7-3; Q15848: ADIPOQ; NbExp=3; IntAct=EBI-11749983, EBI-10827839;
CC       Q9UHP7-3; P27449: ATP6V0C; NbExp=3; IntAct=EBI-11749983, EBI-721179;
CC       Q9UHP7-3; Q9Y2C3: B3GALT5; NbExp=3; IntAct=EBI-11749983, EBI-14141066;
CC       Q9UHP7-3; Q6PL45-2: BRICD5; NbExp=3; IntAct=EBI-11749983, EBI-12244618;
CC       Q9UHP7-3; P34810: CD68; NbExp=3; IntAct=EBI-11749983, EBI-2826276;
CC       Q9UHP7-3; Q8N6F1-2: CLDN19; NbExp=3; IntAct=EBI-11749983, EBI-12256978;
CC       Q9UHP7-3; P57739: CLDN2; NbExp=3; IntAct=EBI-11749983, EBI-751440;
CC       Q9UHP7-3; Q6UVW9: CLEC2A; NbExp=3; IntAct=EBI-11749983, EBI-15839595;
CC       Q9UHP7-3; A0PK11: CLRN2; NbExp=3; IntAct=EBI-11749983, EBI-12813623;
CC       Q9UHP7-3; Q07325: CXCL9; NbExp=3; IntAct=EBI-11749983, EBI-3911467;
CC       Q9UHP7-3; Q5J5C9: DEFB121; NbExp=3; IntAct=EBI-11749983, EBI-10244198;
CC       Q9UHP7-3; Q5MY95-2: ENTPD8; NbExp=3; IntAct=EBI-11749983, EBI-12909060;
CC       Q9UHP7-3; Q7Z2K6: ERMP1; NbExp=3; IntAct=EBI-11749983, EBI-10976398;
CC       Q9UHP7-3; Q92520: FAM3C; NbExp=3; IntAct=EBI-11749983, EBI-2876774;
CC       Q9UHP7-3; Q8TBE3: FNDC9; NbExp=3; IntAct=EBI-11749983, EBI-12142257;
CC       Q9UHP7-3; O15529: GPR42; NbExp=3; IntAct=EBI-11749983, EBI-18076404;
CC       Q9UHP7-3; Q01638-2: IL1RL1; NbExp=3; IntAct=EBI-11749983, EBI-12838366;
CC       Q9UHP7-3; P26715: KLRC1; NbExp=4; IntAct=EBI-11749983, EBI-9018187;
CC       Q9UHP7-3; O95214: LEPROTL1; NbExp=3; IntAct=EBI-11749983, EBI-750776;
CC       Q9UHP7-3; Q16617: NKG7; NbExp=3; IntAct=EBI-11749983, EBI-3919611;
CC       Q9UHP7-3; Q9Y342: PLLP; NbExp=3; IntAct=EBI-11749983, EBI-3919291;
CC       Q9UHP7-3; P26678: PLN; NbExp=3; IntAct=EBI-11749983, EBI-692836;
CC       Q9UHP7-3; P60201-2: PLP1; NbExp=3; IntAct=EBI-11749983, EBI-12188331;
CC       Q9UHP7-3; Q9NS64: RPRM; NbExp=3; IntAct=EBI-11749983, EBI-1052363;
CC       Q9UHP7-3; Q96IW7: SEC22A; NbExp=3; IntAct=EBI-11749983, EBI-8652744;
CC       Q9UHP7-3; Q9BQS2-2: SYT15; NbExp=3; IntAct=EBI-11749983, EBI-13373352;
CC       Q9UHP7-3; Q96CE8: TM4SF18; NbExp=3; IntAct=EBI-11749983, EBI-13351685;
CC       Q9UHP7-3; Q8WZ59: TMEM190; NbExp=3; IntAct=EBI-11749983, EBI-10278423;
CC       Q9UHP7-3; Q96HE8: TMEM80; NbExp=3; IntAct=EBI-11749983, EBI-11742770;
CC       Q9UHP7-3; O14817: TSPAN4; NbExp=3; IntAct=EBI-11749983, EBI-8652667;
CC       Q9UHP7-3; O76024: WFS1; NbExp=3; IntAct=EBI-11749983, EBI-720609;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15104121,
CC       ECO:0000269|PubMed:20843815, ECO:0000305|PubMed:16339513}; Single-pass
CC       type II membrane protein {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:20843815}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:20843815}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q9UHP7-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=Q9UHP7-2; Sequence=VSP_039682;
CC       Name=2;
CC         IsoId=Q9UHP7-3; Sequence=VSP_039683;
CC       Name=4;
CC         IsoId=Q9UHP7-5; Sequence=VSP_039678;
CC       Name=5;
CC         IsoId=Q9UHP7-6; Sequence=VSP_039676;
CC       Name=6;
CC         IsoId=Q9UHP7-7; Sequence=VSP_039676, VSP_039680, VSP_039681;
CC   -!- TISSUE SPECIFICITY: Detected in peripheral blood leukocytes,
CC       osteoblasts, lymph node, thymus and spleen. Isoform 1, isoform 2 and
CC       isoform 4 are expressed in T- and B-lymphocytes, and at lower levels in
CC       NK cells. They are also expressed in B-cell lines and LPS-matured
CC       monocyte-derived dendritic cells. {ECO:0000269|PubMed:10541800,
CC       ECO:0000269|PubMed:20843815}.
CC   -!- INDUCTION: Up-regulated by IL1A/interleukin-1 alpha and prostaglandin
CC       E2 in cultured osteogenic sarcoma cells. {ECO:0000269|PubMed:14753741}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:15104121,
CC       ECO:0000269|PubMed:20843815, ECO:0000269|PubMed:25760607}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=LLT1;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_242";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF133299; AAF22159.1; -; mRNA.
DR   EMBL; AY144606; AAN59996.1; -; Genomic_DNA.
DR   EMBL; FN813349; CBL81070.1; -; mRNA.
DR   EMBL; FN813350; CBL81071.1; -; mRNA.
DR   EMBL; FN813351; CBL81072.1; -; mRNA.
DR   EMBL; AF285087; AAG00514.1; -; mRNA.
DR   EMBL; AF285088; AAG00515.1; -; mRNA.
DR   EMBL; AF285089; AAG00516.1; -; mRNA.
DR   EMBL; AC007068; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471094; EAW96114.1; -; Genomic_DNA.
DR   EMBL; BC019883; AAH19883.1; -; mRNA.
DR   CCDS; CCDS31741.1; -. [Q9UHP7-3]
DR   CCDS; CCDS55800.1; -. [Q9UHP7-5]
DR   CCDS; CCDS55801.1; -. [Q9UHP7-6]
DR   CCDS; CCDS55802.1; -. [Q9UHP7-7]
DR   CCDS; CCDS8602.1; -. [Q9UHP7-1]
DR   RefSeq; NP_001004419.1; NM_001004419.4. [Q9UHP7-3]
DR   RefSeq; NP_001184246.1; NM_001197317.2. [Q9UHP7-6]
DR   RefSeq; NP_001184247.1; NM_001197318.2. [Q9UHP7-5]
DR   RefSeq; NP_001184248.1; NM_001197319.2. [Q9UHP7-7]
DR   RefSeq; NP_037401.1; NM_013269.5. [Q9UHP7-1]
DR   PDB; 4QKG; X-ray; 1.95 A; A=72-191.
DR   PDB; 4QKH; X-ray; 1.80 A; A/B=72-191.
DR   PDB; 4QKI; X-ray; 1.80 A; A/B=72-191.
DR   PDB; 4QKJ; X-ray; 2.75 A; A=72-191.
DR   PDB; 4WCO; X-ray; 2.46 A; A/B/C=71-191.
DR   PDB; 5MGT; X-ray; 1.90 A; A/B=72-191.
DR   PDBsum; 4QKG; -.
DR   PDBsum; 4QKH; -.
DR   PDBsum; 4QKI; -.
DR   PDBsum; 4QKJ; -.
DR   PDBsum; 4WCO; -.
DR   PDBsum; 5MGT; -.
DR   AlphaFoldDB; Q9UHP7; -.
DR   SMR; Q9UHP7; -.
DR   BioGRID; 118886; 223.
DR   IntAct; Q9UHP7; 106.
DR   STRING; 9606.ENSP00000261340; -.
DR   GlyGen; Q9UHP7; 2 sites.
DR   iPTMnet; Q9UHP7; -.
DR   PhosphoSitePlus; Q9UHP7; -.
DR   BioMuta; CLEC2D; -.
DR   DMDM; 74753331; -.
DR   MassIVE; Q9UHP7; -.
DR   PeptideAtlas; Q9UHP7; -.
DR   PRIDE; Q9UHP7; -.
DR   ProteomicsDB; 84389; -. [Q9UHP7-1]
DR   ProteomicsDB; 84390; -. [Q9UHP7-2]
DR   ProteomicsDB; 84391; -. [Q9UHP7-3]
DR   ProteomicsDB; 84393; -. [Q9UHP7-6]
DR   Antibodypedia; 2229; 279 antibodies from 31 providers.
DR   DNASU; 29121; -.
DR   Ensembl; ENST00000261339.10; ENSP00000261339.6; ENSG00000069493.15. [Q9UHP7-6]
DR   Ensembl; ENST00000261340.11; ENSP00000261340.7; ENSG00000069493.15. [Q9UHP7-3]
DR   Ensembl; ENST00000290855.11; ENSP00000290855.6; ENSG00000069493.15. [Q9UHP7-1]
DR   Ensembl; ENST00000479877.5; ENSP00000441653.1; ENSG00000069493.15. [Q9UHP7-2]
DR   Ensembl; ENST00000543300.5; ENSP00000443065.1; ENSG00000069493.15. [Q9UHP7-5]
DR   Ensembl; ENST00000545918.5; ENSP00000444818.1; ENSG00000069493.15. [Q9UHP7-7]
DR   GeneID; 29121; -.
DR   KEGG; hsa:29121; -.
DR   MANE-Select; ENST00000290855.11; ENSP00000290855.6; NM_013269.6; NP_037401.1.
DR   UCSC; uc001qwf.4; human. [Q9UHP7-1]
DR   CTD; 29121; -.
DR   DisGeNET; 29121; -.
DR   GeneCards; CLEC2D; -.
DR   HGNC; HGNC:14351; CLEC2D.
DR   HPA; ENSG00000069493; Tissue enhanced (lymphoid).
DR   MIM; 605659; gene.
DR   neXtProt; NX_Q9UHP7; -.
DR   OpenTargets; ENSG00000069493; -.
DR   PharmGKB; PA142672100; -.
DR   VEuPathDB; HostDB:ENSG00000069493; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000155319; -.
DR   HOGENOM; CLU_049894_8_4_1; -.
DR   InParanoid; Q9UHP7; -.
DR   OMA; PAINANC; -.
DR   OrthoDB; 1289964at2759; -.
DR   PhylomeDB; Q9UHP7; -.
DR   TreeFam; TF351467; -.
DR   PathwayCommons; Q9UHP7; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   SignaLink; Q9UHP7; -.
DR   BioGRID-ORCS; 29121; 11 hits in 1072 CRISPR screens.
DR   ChiTaRS; CLEC2D; human.
DR   GeneWiki; CLEC2D; -.
DR   GenomeRNAi; 29121; -.
DR   Pharos; Q9UHP7; Tbio.
DR   PRO; PR:Q9UHP7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9UHP7; protein.
DR   Bgee; ENSG00000069493; Expressed in granulocyte and 115 other tissues.
DR   ExpressionAtlas; Q9UHP7; baseline and differential.
DR   Genevisible; Q9UHP7; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046703; F:natural killer cell lectin-like receptor binding; IBA:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   CDD; cd03593; CLECT_NK_receptors_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR033992; NKR-like_CTLD.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Lectin; Membrane; Receptor;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..191
FT                   /note="C-type lectin domain family 2 member D"
FT                   /id="PRO_0000315285"
FT   TOPO_DOM        1..38
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        39..59
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        60..191
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          82..185
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   CARBOHYD        95
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25760607,
FT                   ECO:0007744|PDB:4QKG, ECO:0007744|PDB:4QKH,
FT                   ECO:0007744|PDB:4QKJ"
FT   CARBOHYD        147
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25826155,
FT                   ECO:0007744|PDB:4QKH"
FT   DISULFID        75..86
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040,
FT                   ECO:0007744|PDB:4QKG, ECO:0007744|PDB:4QKH,
FT                   ECO:0007744|PDB:4QKI, ECO:0007744|PDB:4QKJ,
FT                   ECO:0007744|PDB:4WCO"
FT   DISULFID        103..184
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040,
FT                   ECO:0007744|PDB:4QKG, ECO:0007744|PDB:4QKH,
FT                   ECO:0007744|PDB:4QKI, ECO:0007744|PDB:4QKJ,
FT                   ECO:0007744|PDB:4WCO"
FT   VAR_SEQ         21..57
FT                   /note="Missing (in isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:20843815"
FT                   /id="VSP_039676"
FT   VAR_SEQ         120..191
FT                   /note="NFLLRYKGPSDHWIGLSREQGQPWKWINGTEWTRQFPILGAGECAYLNDKGA
FT                   SSARHYTERKWICSKSDIHV -> VSYPGSRRVCLFE (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:20843815, ECO:0000303|Ref.4"
FT                   /id="VSP_039678"
FT   VAR_SEQ         120..132
FT                   /note="NFLLRYKGPSDHW -> VSYPGSRRVCLFE (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:20843815"
FT                   /id="VSP_039680"
FT   VAR_SEQ         133..191
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:20843815"
FT                   /id="VSP_039681"
FT   VAR_SEQ         155..191
FT                   /note="FPILGAGECAYLNDKGASSARHYTERKWICSKSDIHV -> LVMKEDGANLY
FT                   VAKVSQVPRMNPRPVMVSYPGSRRVCLFE (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_039683"
FT   VAR_SEQ         155..191
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039682"
FT   VARIANT         19
FT                   /note="N -> K (in dbSNP:rs16914640)"
FT                   /evidence="ECO:0000269|PubMed:20843815"
FT                   /id="VAR_038172"
FT   VARIANT         23
FT                   /note="L -> V (in dbSNP:rs3764022)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:20843815"
FT                   /id="VAR_038173"
FT   STRAND          80..82
FT                   /evidence="ECO:0007829|PDB:4QKH"
FT   STRAND          85..89
FT                   /evidence="ECO:0007829|PDB:4QKH"
FT   HELIX           96..105
FT                   /evidence="ECO:0007829|PDB:4QKH"
FT   HELIX           116..126
FT                   /evidence="ECO:0007829|PDB:4QKH"
FT   STRAND          131..136
FT                   /evidence="ECO:0007829|PDB:4QKH"
FT   STRAND          148..150
FT                   /evidence="ECO:0007829|PDB:4QKI"
FT   STRAND          157..160
FT                   /evidence="ECO:0007829|PDB:4WCO"
FT   STRAND          162..166
FT                   /evidence="ECO:0007829|PDB:4QKH"
FT   STRAND          168..174
FT                   /evidence="ECO:0007829|PDB:4QKH"
FT   STRAND          180..187
FT                   /evidence="ECO:0007829|PDB:4QKH"
SQ   SEQUENCE   191 AA;  21849 MW;  E71F3E21DC361F10 CRC64;
     MHDSNNVEKD ITPSELPANP GCLHSKEHSI KATLIWRLFF LIMFLTIIVC GMVAALSAIR
     ANCHQEPSVC LQAACPESWI GFQRKCFYFS DDTKNWTSSQ RFCDSQDADL AQVESFQELN
     FLLRYKGPSD HWIGLSREQG QPWKWINGTE WTRQFPILGA GECAYLNDKG ASSARHYTER
     KWICSKSDIH V
//
